Amherst, NH, United States of America

Gary Michael Ksander

USPTO Granted Patents = 36 


 

Average Co-Inventor Count = 2.3

ph-index = 10

Forward Citations = 680(Granted Patents)


Location History:

  • Carmel, NY (US) (1987 - 1992)
  • Milford, NJ (US) (1990 - 2014)
  • Boston, MA (US) (2014)
  • Amherst, MA (US) (2013 - 2016)
  • Amherst, NH (US) (2008 - 2017)

Company Filing History:


Years Active: 1987-2017

Loading Chart...
Loading Chart...
Loading Chart...
36 patents (USPTO):Explore Patents

Title: **Gary Michael Ksander: A Pioneer in Pharmaceutical Innovations**

Introduction

Gary Michael Ksander, located in Amherst, NH, has made significant contributions to pharmaceutical sciences with an impressive portfolio of 36 patents. His groundbreaking inventions focus on treating various medical disorders through innovative chemical compounds, showcasing his commitment to improving healthcare.

Latest Patents

Among his latest inventions, Ksander has developed substituted aminobutyric derivatives as neprilysin inhibitors. This invention provides a novel compound, which offers therapeutic uses in treating diseases associated with dysfunctional hormone levels. Another significant patent pertains to the use of an adrenal hormone-modifying agent, detailing methods for addressing conditions characterized by increased stress hormone levels and decreased androgen hormone levels. These patents not only highlight Ksander's inventive spirit but also his dedication to advancing medical treatments through pharmacological research.

Career Highlights

Gary Michael Ksander has worked with esteemed companies such as Novartis AG and Ciba-Geigy Corporation, where he utilized his expertise in the field of pharmaceuticals to foster innovation and product development. His work has significantly impacted the pharmaceutical industry, leading to advancements in drug formulations and therapeutic approaches.

Collaborations

Throughout his career, Ksander has collaborated with notable peers, including Yuki Iwaki and Toshio Kawanami. These collaborations have enabled the exchange of ideas and fostered an environment for innovative thinking, ultimately contributing to advancements in pharmaceutical research.

Conclusion

In conclusion, Gary Michael Ksander's contributions to the field of pharmaceuticals are profound and far-reaching. With his extensive patent portfolio and valuable collaborations, he continues to be a key figure in the advancement of therapeutic innovations. His work exemplifies the importance of creativity and scientific inquiry in addressing healthcare challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…